Fintel reports that on December 13, 2024, Stifel initiated coverage of ResMed Inc. - Depositary Receipt () (ASX:RMD) with a Hold recommendation.
Analyst Price Forecast Suggests 4.32% Upside
As of December 3, 2024, the average one-year price target for ResMed Inc. - Depositary Receipt () is $39.28/share. The forecasts range from a low of $29.59 to a high of $45.82. The average price target represents an increase of 4.32% from its latest reported closing price of $37.65 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for ResMed Inc. - Depositary Receipt () is 4,828MM, an increase of 0.43%. The projected annual non-GAAP EPS is 8.23.
What is the Fund Sentiment?
There are 9 funds or institutions reporting positions in ResMed Inc. - Depositary Receipt (). This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to RMD is 1.82%, an increase of 12.54%. Total shares owned by institutions decreased in the last three months by 2.22% to 5,841K shares.
What are Other Shareholders Doing?
Bernstein Fund Inc - International Strategic Equities Portfolio SCB Class holds 4,994K shares. No change in the last quarter.
AB VARIABLE PRODUCTS SERIES FUND, INC. - AB International Value Portfolio holds 285K shares. In its prior filing, the firm reported owning 306K shares , representing a decrease of 7.36%. The firm increased its portfolio allocation in RMD by 16.35% over the last quarter.
Aberdeen Australia Equity Fund holds 235K shares. In its prior filing, the firm reported owning 213K shares , representing an increase of 9.60%. The firm increased its portfolio allocation in RMD by 1.84% over the last quarter.
ABIAX - AB International Value Fund holds 107K shares. In its prior filing, the firm reported owning 107K shares , representing an increase of 0.09%. The firm increased its portfolio allocation in RMD by 12.44% over the last quarter.
SINE - Martin Currie Sustainable International Equity ETF holds 80K shares. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
